{
  "docId": "019de073-3800-772b-871e-98f0ed79adc7",
  "docSlug": "3d30d84bb133b7b226440021781a4f91",
  "documentTitle": "23andMe | Investor Presentation Deck | 58 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 43,
  "pageCount": 58,
  "prevPage": 42,
  "nextPage": 44,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 27,
  "notes": "The chart demonstrates efficacy of the drug candidate 23ME '610 in an ex vivo assay.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-3800-772b-871e-98f0ed79adc7/43",
  "deckHref": "/decks/019de073-3800-772b-871e-98f0ed79adc7",
  "deckJsonHref": "/decks/019de073-3800-772b-871e-98f0ed79adc7.json",
  "deckAnchorHref": "/decks/019de073-3800-772b-871e-98f0ed79adc7#slide-43",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.7,
        "x": 0.15,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Interferon-gamma fold change relative to control across 9 patient samples",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "571e9ab7-ef1c-4ad8-8178-44af44faee48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "paragraph",
      "text": "PBMCs from each respective patient were incubated with 100 nM of 23ME-00610, anti-PD-1, or isotype control. Cells were stimulated with SEB. IFNy levels were determined by enzyme-linked immunosorbent assay. Mean biologic triplicates were normalized to isotype control. *P <0.05.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40ef3b39-fe12-46eb-aecb-07af2e36d079",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.85,
        "y": 0.8
      },
      "kind": "source-note",
      "text": "PBMC, peripheral blood mononuclear cell; PD-1, programmed death-1; SEB, staphylococcal enterotoxin B.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7150cb5f-774a-4a78-8166-0686a0c0f268",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "title",
      "text": "Blocking the CD200R1 pathway enhanced IFNy production from SEB-stimulated PBMCs compared to isotype control and anti-PD1 in the majority of samples tested",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f48b9b6-72cb-4f02-a164-e9b9ecaffdfb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Inhibition of CD200R1 has the potential to address resistance to anti-PD1 therapies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f88f35a-ad3d-4d9e-ae0f-07275805fcfc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}